Research Topics
| Philip D HarveySummaryAffiliation: Emory University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Abbreviated neuropsychological assessment in schizophrenia: prediction of different aspects of outcomePhilip D Harvey
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30032, USA
J Clin Exp Neuropsychol 31:462-71. 2009..Future studies should determine whether responses to pharmacological and remediation treatments can be captured with brief assessments as well...
Pharmacological cognitive enhancement in schizophreniaPhilip D Harvey
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Woodruff Memorial Building, 101 Woodruff Circle, Suite 4000, Atlanta, GA 30322, USA
Neuropsychol Rev 19:324-35. 2009..It is likely that this will be an area of research that will be developing extensively over the next decade and expanding to other conditions as well...
Performance-based measurement of functional disability in schizophrenia: a cross-national study in the United States and SwedenPhilip D Harvey
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Woodruff Memorial Building, 101 Woodruff Circle, Suite 4000, Atlanta, GA 30322, USA
Am J Psychiatry 166:821-7. 2009..The authors examined the similarity of performance-based assessments of everyday functioning, real-world disability, and achievement of milestones in people with schizophrenia in the United States and Sweden...
Cognition and disability in bipolar disorder: lessons from schizophrenia researchPhilip D Harvey
Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA 30322, USA
Bipolar Disord 12:364-75. 2010....
The influence of demographic factors on functional capacity and everyday functional outcomes in schizophreniaFelicia Gould
Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL 33136, USA
J Clin Exp Neuropsychol 34:467-75. 2012..Older age contributed to poorer everyday functioning even after consideration of functional capacity, which seems similar to findings in healthy populations without clinically notable cognitive decline...
The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacityRichard S E Keefe
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
Am J Psychiatry 163:426-32. 2006..This study describes the reliability and validity of a new interview-based assessment of cognition, the Schizophrenia Cognition Rating Scale (SCoRS), that involves interviews with patients and informants...
Validating the measurement of real-world functional outcomes: phase I results of the VALERO studyPhilip D Harvey
Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, FL 33136, USA
Am J Psychiatry 168:1195-201. 2011....
Assessing everyday functioning in schizophrenia: not all informants seem equally informativeSamir Sabbag
Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1120NW14th Street, Miami, FL 33136, USA
Schizophr Res 131:250-5. 2011..Later analyses will determine if there are differences between friend or relative informants...
A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatmentPhilip D Harvey
Department of Psychiatry, Emory University School of Medicine, Atlanta, GA 30032, United States
Schizophr Res 105:138-43. 2008..This study compared the cognitive benefits of clozapine and ziprasidone in schizophrenia patients (n=130) with a history of either failure to respond to or intolerance of previous adequate antipsychotic treatments...
Neuropsychological function and dysfunction in schizophrenia and psychotic affective disordersAbraham Reichenberg
Department of Psychiatry, Emory University School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA
Schizophr Bull 35:1022-9. 2009..NP normality in psychotic affective disorders has not been systematically studied...
Reduction of functional disability with atypical antipsychotic treatment: a randomized long term comparison of ziprasidone and haloperidolPhilip D Harvey
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
Schizophr Res 115:24-9. 2009..This study examined the process of development of "functional remission" in a long-term comparative double-blind study of haloperidol and the atypical antipsychotic medication ziprasidone...
The course of neuropsychological performance and functional capacity in older patients with schizophrenia: influences of previous history of long-term institutional stayPhilip D Harvey
Department of Psychiatry, Emory University School of Medicine, Atlanta, Georgia 30322, USA
Biol Psychiatry 67:933-9. 2010..The present study examined older outpatients who varied in their lifetime history of long-term psychiatric inpatient stay...
Determinants of everyday outcomes in schizophrenia: the influences of cognitive impairment, functional capacity, and symptomsFeea R Leifker
Emory University School of Medicine, Atlanta, GA 30322, USA
Schizophr Res 115:82-7. 2009..For social and everyday living outcomes, variance accounted for by the entire array of predictive variables was less than 40%, suggesting that other factors, such as social and cultural influences, are involved as well...
Factors associated with functional recovery in bipolar disorder patientsAliza P Wingo
Department of Psychiatry, Emory University, Atlanta, GA 30322, USA
Bipolar Disord 12:319-26. 2010..As several factors have tentatively been implicated in outcomes in BPD, we investigated predictors of functional recovery among BPD patients, including demographic, clinical, and neurocognitive factors...
Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panelFeea R Leifker
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
Schizophr Bull 37:334-43. 2011....
Correlates of recovery of social functioning in types I and II bipolar disorder patientsAliza P Wingo
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA 30322, USA
Psychiatry Res 177:131-4. 2010..I), co-morbid psychiatric illness, and executive functioning status. The findings are consistent with deleterious effects of even residual depressive symptoms in BPD patients...
Implementation considerations for multisite clinical trials with cognitive neuroscience tasksRichard S E Keefe
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Box 3270, Durham, NC 27710, USA
Schizophr Bull 34:656-63. 2008..Suggestions for overcoming these implementation challenges are offered...
Performance-based assessment of functional skills in severe mental illness: results of a large-scale study in ChinaBelinda J McIntosh
Emory University School of Medicine, USA
J Psychiatr Res 45:1089-94. 2011..These data suggest that in developing countries educational attainment may be strongly associated with levels of adaptive outcomes and the utilization and interpretation of functional capacity measures be adjusted accordingly...
Effects of lithium on cognitive performance: a meta-analysisAliza P Wingo
Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA 30322, USA
J Clin Psychiatry 70:1588-97. 2009..Among these, lithium is the best-studied mood stabilizer. As its cognitive effects are mixed and not well-known, we assessed reported effects of lithium on cognitive performance...
The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatmentPhilip D Harvey
epartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Woodruff Memorial Building, 101 Woodruff Circle, Suite 4000, Atlanta, GA 30322, USA
Bipolar Disord 10:900-6. 2008..We hypothesized, consistent with recent studies of schizophrenia, that the factor structure after treatment would be similar to the structure of untreated symptoms at study baseline...
Neurocognitive impairment in bipolar disorder patients: functional implicationsAliza P Wingo
Department of Psychiatry and Behavioral Sciences, Emory University, 101 Woodruff Circle NE, Atlanta, GA 30322, USA
Bipolar Disord 11:113-25. 2009..We hypothesized that increasingly well-documented aspects of cognitive impairment may contribute to poor functional outcomes in BPD patients, and reviewed the available research on the topic...
The factor structure of clinical symptoms in depressed inpatients with unipolar or bipolar spectrum disorders: a preliminary studyPhilip D Harvey
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA
J Nerv Ment Dis 197:161-5. 2009..Our results suggest that similar levels of symptom severity may have different underpinnings in the 2 groups and suggest that more comparative studies of symptoms in these 2 conditions may be useful...
The broad importance of cognitive impairments in aging-related disordersPhilip D Harvey
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia
Am J Geriatr Psychiatry 16:99-101. 2008
Baseline neurocognitive deficits in the CATIE schizophrenia trialRichard S E Keefe
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
Neuropsychopharmacology 31:2033-46. 2006..Multiple analyses suggested that a broad cognitive deficit characterizes this sample. These deficits are modestly related to negative symptoms and essentially independent of positive symptom severity...
The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcomeRichard S E Keefe
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
J Clin Exp Neuropsychol 28:260-9. 2006..They also suggest that the measures being considered as potential co-primary indicators of cognitive function for registration trials are significantly correlated with cognition as assessed by brief cognitive assessments...
Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approachesPhilip D Harvey
Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1120 North West 14th Street, Suite 1450, Miami, FL 33136, USA
Psychiatr Clin North Am 35:683-98. 2012....
The effects of child abuse and neglect on cognitive functioning in adulthoodFelicia Gould
Department of Psychiatry and Behavioral Sciences, University of Miami Leonard M Miller School of Medicine, Miami, FL 33136, USA
J Psychiatr Res 46:500-6. 2012..Additionally, we hypothesized that the nature and magnitude of cognitive deficits would differ according to the subtype of ELS experienced...
The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive batteryRichard S E Keefe
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, P O Box 3270, Durham, NC 27710, USA
Schizophr Res 68:283-97. 2004..76) and healthy controls (r=0.90). These psychometric properties make the BACS a promising tool for assessing cognition repeatedly in patients with schizophrenia, especially in clinical trials of cognitive enhancement...
Evaluation of dementia rating scales in Parkinson's disease dementiaPhilip D Harvey
Emory University School of Medicine, 101 Woodruff Circle, Atlanta, GA 30322, USA
Am J Alzheimers Dis Other Demen 25:142-8. 2010..This supports the validity of previous results obtained with these measures in studies of patients with PDD...
Self-assessment of functional ability in schizophrenia: Milestone achievement and its relationship to accuracy of self-evaluationFelicia Gould
Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA
Psychiatry Res 207:19-24. 2013..As many patients with schizophrenia never achieve milestones, their self-assessment may be overly optimistic as a result...
Impairment in functional capacity as an endophenotype candidate in severe mental illnessPhilip D Harvey
Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1120 NW 14th Street, Suite 1450, Miami, FL 33136, USA
Schizophr Bull 38:1318-26. 2012....
Pharmaco-genetically guided treatment of recurrent rage outbursts in an adult male with 15q13.3 deletion syndromeJoseph F Cubells
Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA
Am J Med Genet A 155:805-10. 2011..3DS-associated rage outbursts...
From clinical research to clinical practice: a 4-year review of ziprasidoneCharles B Nemeroff
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 101 Woodruff Circle, Atlanta, GA 30322, USA
CNS Spectr 10:1-20. 2005..This monograph summarizes the efficacy, tolerability, and safety of oral ziprasidone in the treatment of schizophrenia, schizoaffective disorder, and bipolar mania...
Subscale structure for the Positive and Negative Syndrome Scale (PANSS): a proposed solution focused on clinical validityMary E Kelley
Department of Biostatistics and Bioinformatics, Emory University, Rollins School of Public Health, 1518 Clifton Road NE, Atlanta, GA 30329, USA
Psychiatry Res 205:137-42. 2013....
